MedTrace Logo

Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment

NCT01198457 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 147

Last updated 2012-09-07

No results posted yet for this study

Summary

Adherence (or compliance with) a medication regimen is generally defined as the extent to which patients take medication as prescribed by their health care providers. The adherence to medications has close relation to effectiveness of the therapy. The primary objective of this study is to observe the adherence to treatment with oral clodronate (PDC, proportion of days covered, number of days in which clodronate is taken according to treating physician recommendation) in patients with malignancy. The secondary "hypothesis generating" objective is to describe the relation between adherence to treatment with oral clodronate and efficacy of the therapy (skeletal events, pain).

Conditions

Interventions

DRUG

Clodronate (Bonefos, BAY94-8393)

Random group of patients in oncology clinic

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Czechia

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01198457 on ClinicalTrials.gov